Correction to: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)

Zachary M. Avigan, Suzanne Arinsburg, Darren Pan, Tomer Mark, Christopher Fausel, Joseph Bubalo, Gary Milkovich, Erin Moshier, Weijia Fu, Ajai Chari, Joshua Richter

Research output: Contribution to journalComment/debate

Abstract

Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-024-02385-1, published online 31 July 2024 Following the publication of this article it was noted that two authors were omitted: Erin Moshier1 and Weijia Fu11Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. These authors have now been added to the author list. The Competing Interests statement has been updated as follows: DP: honoraria from Sanofi. TM: Employment at Karyopharm Therapeutics. AC: consulting for Sanofi. JR: consulting and honoraria from Sanofi. ZMA, SA, CF, JB, EM, WF and GM have no relevant conflicts of interest to disclose. The original article has been corrected.

Original languageEnglish
JournalBone Marrow Transplantation
DOIs
StateAccepted/In press - 2024

Fingerprint

Dive into the research topics of 'Correction to: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)'. Together they form a unique fingerprint.

Cite this